Stilbestrol Administration in the Puerperium and its Effect on the Prolactin Excretion of Non‐Lactating Patients
- 12 January 1977
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 56 (3) , 211-215
- https://doi.org/10.3109/00016347709162122
Abstract
The relationship between stilbestrol treatment and placebo treatment was studied in 2 groups of non‐nursing patients. Plasma prolactin levels were evaluated in these 2 groups on day 1, 3 and 7 of the treatment, by a radioimmunoassay technique with the double antibody method using Serono hPRL kit. Our results show that prolactin values increased significantly in the stilbestrol‐group and decreased in the placebo group. It seems that the main reason for “the drying up of milk” is the lack of stimulation of the nipples, which after a relatively constant time of 5–10 days will lead to decreased prolactin levels. Stilbestrol treatment is not effective in “drying up” the milk more rapidly in patients who do not want to nurse. When patients have symptoms a combination of analgesia and breast support usually brings relief within 24 to 48 hours.This publication has 7 references indexed in Scilit:
- The Influence of Prolactin Secretion on Human LactationJournal of Clinical Endocrinology & Metabolism, 1975
- THE INHIBITION OF LACTATION BY CLOMIPHENEBJOG: An International Journal of Obstetrics and Gynaecology, 1973
- A Homologous Radioimmunoassay for Human Prolactin1Journal of Clinical Endocrinology & Metabolism, 1973
- Human Lactational and Ovarian Response to Endogenous Prolactin ReleaseScience, 1972
- Inhibition of lactation with combined oestrogen and progestogen.BMJ, 1968
- Inhibition of lactation with quinestrol.BMJ, 1968
- SUPPRESSION OF LACTATION: A Double-blind TrialThe Lancet, 1965